FDA Update/Outlook for 2022

Please join partners Michele L. Buenafe and Dennis C. Gucciardo for a discussion on 2022 Food and Drug Administration (FDA) hot topics in the digital health space, including the FDA’s focus on cybersecurity, artificial intelligence and machine learning, and clinical decision support software; developments related to the use of digital health technologies in clinical studies and related to COVID-19; and anticipated enforcement trends.